Indeed, treatment of breast cancer cells with ACAT-1 inhibitors resulted in reduced cell proliferation and migration and reduced tumor growth through regulation of cholesterol metabolism (Antalis et al., 2010; Shim et al., 2018). Here, ACAT1 is linked to neoplasm.